Ebysta Merap gastrointestinal medicine for gastroesophageal reflux disease (20 packs x 10ml)

Dosage form Chaos
Specifications Box of 20 packs
Ingredient Sodium alginate, calcium carbonate, sodium bicarbonate

Ingredient

Composition information	Content
Sodium alginate	500mg
Calcium carbonate	160mg
Sodium bicarbonate	267mg

Uses

indications

Ebysta drug prescribed to treat gastroesophageal reflux disease, heartburn, flatulence related to reflux, heartburn during pregnancy, all cases of epigastric pain and behind the sternum related to gastroesophageal reflux.

Pharmacokology

There is no reported information.

pharmacokinetics

There is no reported information.

Before taking Ebysta Merap gastrointestinal medicine for gastroesophageal reflux disease (20 packs x 10ml)

How to use

Ebysta drugs for oral fluid, shake the drug before use.

Dosage

Patients are recommended for medication after meals and before going to bed (up to 4 times/day)

Adults and children aged 12 and older: Take 10-20 ml/time. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose? In case of overdose medication, patients need to treat symptoms.

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

When using Ebysta, you may experience unwanted effects (ADR).

Unwanted effects are classified according to the frequency of the following conventions: Very common: ≥1/10, common: ≥1/100 to Agency system frequency unwanted effects Interior is very rare effects on the respiratory tract such as bronchial spasm

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Ebysta drugs contraindicated in the following cases:

Patients who have known or suspected symptoms of hypersensitivity to the ingredients and excipients of the drug

Be cautious when using

If the symptoms do not improve after 7 days of use, patients need to be assessed for clinical status.

The sodium content in 10 ml is 141 mg (6.2 mmol). Therefore, it is necessary to calculate appropriately when used in patients who require salt diet such as congestive heart failure and kidney failure.

Calcium carbonate content in 10 ml is 160 mg (1.6 mmol). Careful when treating drugs for patients with hypercalca hypercalcemia, retaining kidney calcium, recurrent renal calcium stones.

Methyl parahydroxybenzoate drugs, propyl parahydroxybenzoate propyl can cause allergies (late allergic reactions).

Use drugs for pregnant or nursing women

Pregnant women:

Clinical studies and data obtained from oral circulation containing sodium alginate, calcium carbonate, sodium bicarbonate show that the active ingredient of the drug does not cause defects or toxicity on the fetus.

The drug can be used during pregnancy when necessary

breastfeeding women:

There is no effect of the active ingredient on breastfeeding children recorded when the mother uses the drug

The drug can be used in breastfeeding women

affects the ability to drive and operate machinery

Ebysta does not affect the ability to drive and operate machinery.

Drug interactions

Should consider using Ebysta about 2 hours away with other drugs, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron Salt, Ketoconazole, Sedative, Thyroid Hormones, Penicillanine, High blood pressure medications (Atenololol, Metoprolol Propanolol, glucocorticoid, chloroquine, biphosphonates (diphosphonates) and estramustine/

Storage

Leave a cool place, avoid light, temperature below 30⁰C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.